𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Large genomic rearrangements and germline epimutations in Lynch syndrome

✍ Scribed by Annette Gylling; Maaret Ridanpää; Outi Vierimaa; Kristiina Aittomäki; Kristiina Avela; Helena Kääriäinen; Hannele Laivuori; Minna Pöyhönen; Satu-Leena Sallinen; Carina Wallgren-Pettersson; Heikki J. Järvinen; Jukka-Pekka Mecklin; Paivi Peltomäki


Publisher
John Wiley and Sons
Year
2009
Tongue
French
Weight
269 KB
Volume
124
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

In one‐third of families fulfilling the Amsterdam criteria for hereditary nonpolyposis colorectal cancer/Lynch syndrome, and a majority of those not fulfilling these criteria point mutations in DNA mismatch repair (MMR) genes are not found. The role of large genomic rearrangements and germline epimutations in MLH1, MSH2 and MSH6 was evaluated in 2 such cohorts. All 45 index patients were mutation‐negative by genomic sequencing and testing for a prevalent population‐specific founder mutation, and selectively lacked MMR protein expression in tumor tissue. Eleven patients (“research cohort”) represented 11 mutation‐negative families among 81 verified or putative Lynch syndrome families from the nation‐wide Hereditary Colorectal Cancer Registry of Finland. Thirty‐four patients from 33 families (“clinic‐based cohort”) represented suspected Lynch syndrome patients tested for MMR gene mutations in a diagnostic laboratory during 2004–2007. Multiplex ligation‐dependent probe amplification (MLPA) and methylation‐specific (MS)‐MLPA were used to detect rearrangements and epimutations, respectively. Large genomic deletions occurred in 12/45 patients (27%), being present in 3/25 (12%), 9/16 (56%) and 0/4 (0%) among index patients lacking MLH1, MSH2 or MSH6 expression, respectively. Germline epimutations of MLH1, one of which coexisted with a genomic deletion, occurred in 2 patients (4%) and were accompanied by monoallelic expression in mRNA. Large genomic deletions (mainly MSH2) and germline epimutations (MLH1) together explain a significant fraction of point mutation‐negative families suspected of Lynch syndrome and are associated with characteristic clinical and family features. Our findings have important implications in the diagnosis and management of such families. © 2008 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


Large genomic rearrangements in MECP2
✍ Kirstine Ravn; Jytte Bieber Nielsen; Ola Husbeth Skjeldal; Alison Kerr; Maj Hult 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB

In 1999, mutations in the X-linked gene methyl-CpG-binding protein 2 (MECP2) were first reported in patients with Rett syndrome (RTT). The MECP2 gene is located at Xq28 and consists of 4 exons. About 80-90 % of the classic RTT patients harbor mutations in the coding region of MECP2, while the molecu

Recurrence and variability of germline E
✍ Roland P. Kuiper; Lisenka E.L.M. Vissers; Ramprasath Venkatachalam; Danielle Bod 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 335 KB

Recently, we identified 3' end deletions in the EPCAM gene as a novel cause of Lynch syndrome. These truncating EPCAM deletions cause allele-specific epigenetic silencing of the neighboring DNA mismatch repair gene MSH2 in tissues expressing EPCAM. Here we screened a cohort of unexplained Lynch-like

Identification and characterization of g
✍ Hidewaki Nakagawa; Heather Hampel; Albert de la Chapelle 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 201 KB 👁 1 views

It has recently been suggested that large genomic rearrangements account for 10-20% of all MSH2 mutations, and a lower proportion of all MLH1 mutations, among individuals with Lynch syndrome (hereditary non-polyposis colorectal cancer, HNPCC). These rearrangements are notoriously difficult to detect

Quantitative PCR high-resolution melting
✍ Etienne Rouleau; Cédrick Lefol; Violaine Bourdon; Florence Coulet; Tetsuro Noguc 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 427 KB

Several techniques have been developed to screen mismatch repair (MMR) genes for deleterious mutations. Until now, two different techniques were required to screen for both point mutations and large rearrangements. For the first time, we propose a new approach, called "quantitative PCR (qPCR) high-r

High proportion of large genomic STK11 d
✍ Stefan Aretz; Dietlinde Stienen; Siegfried Uhlhaas; Steffan Loff; Walter Back; C 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 235 KB

Germline mutations in the STK11 gene have been identified in 10-70% of patients with Peutz-Jeghers syndrome (PJS), an autosomal-dominant hamartomatous polyposis syndrome. A second locus was assumed in a large proportion of PJS patients. To date, STK11 alterations comprise mainly point mutations; onl